These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 10826326)

  • 1. [The attitude of pregnant women to the possibilities for the prenatal screening and diagnosis of Down's syndrome in the 2nd trimester].
    Dimitrova V; Chernev T; Savova S; Stoianova M
    Akush Ginekol (Sofiia); 2000; 39(1):3-9. PubMed ID: 10826326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women as moral pioneers? Experiences of first trimester antenatal screening.
    Williams C; Sandall J; Lewando-Hundt G; Heyman B; Spencer K; Grellier R
    Soc Sci Med; 2005 Nov; 61(9):1983-92. PubMed ID: 15899542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study.
    Bishop AJ; Marteau TM; Armstrong D; Chitty LS; Longworth L; Buxton MJ; Berlin C
    BJOG; 2004 Aug; 111(8):775-9. PubMed ID: 15270923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding pregnant women's decision making concerning prenatal screening.
    van den Berg M; Timmermans DR; Knol DL; van Eijk JT; de Smit DJ; van Vugt JM; van der Wal G
    Health Psychol; 2008 Jul; 27(4):430-7. PubMed ID: 18643000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
    Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
    Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
    Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
    Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey.
    Gourounti K; Sandall J
    Midwifery; 2008 Jun; 24(2):153-62. PubMed ID: 17316936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester Down syndrome screening: public health implications.
    Fuchs KM; Peipert JF
    Semin Perinatol; 2005 Aug; 29(4):267-71. PubMed ID: 16104680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ethical aspects of disclosing information on prenatal screening for Down's syndrome].
    Tóth A; Szabó J
    Orv Hetil; 2005 Feb; 146(6):259-65. PubMed ID: 15779814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's and health professionals' preferences for prenatal testing for Down syndrome in Australia.
    Lewis SM; Cullinane FM; Carlin JB; Halliday JL
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):205-11. PubMed ID: 16704474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL;
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnant women's attitudes toward amniocentesis before receiving Down syndrome screening results.
    Brajenović-Milić B; Babić I; Ristić S; Vraneković J; Brumini G; Kapović M
    Womens Health Issues; 2008; 18(2):79-84. PubMed ID: 18180167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum screening for Down syndrome: are women's perceptions changing?
    Gidiri M; McFarlane J; Holding S; Lindow S
    BJOG; 2007 Apr; 114(4):458-61. PubMed ID: 17378818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice.
    Rowe HJ; Fisher JR; Quinlivan JA
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):433-9. PubMed ID: 16953859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital anomalies: parents' anxiety and women's concerns before prenatal testing and women's opinions towards the risk factors.
    Sahin NH; Gungor I
    J Clin Nurs; 2008 Mar; 17(6):827-36. PubMed ID: 18279286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informed choice in women attending private clinics to undergo first-trimester screening for Down syndrome.
    Jaques AM; Sheffield LJ; Halliday JL
    Prenat Diagn; 2005 Aug; 25(8):656-64. PubMed ID: 16049990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies.
    Weisz B; Rodeck CH
    Hum Reprod Update; 2006; 12(5):513-8. PubMed ID: 16672245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's opinions on the offer and use of nuchal translucency screening for Down syndrome.
    Müller MA; Bleker OP; Bonsel GJ; Bilardo CM
    Prenat Diagn; 2006 Feb; 26(2):105-11. PubMed ID: 16463289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of prenatal diagnosis intervention for Down's syndrome in China.
    Chen Y; Qian X; Li J; Zhang J; Chu A; Schweitzer SO
    Int J Technol Assess Health Care; 2007; 23(1):138-45. PubMed ID: 17234028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility assessment of Chinese pregnant women towards the birth of a baby with Down syndrome compared to a procedure-related miscarriage.
    Chan YM; Leung TN; Leung TY; Fung TY; Chan LW; Lau TK
    Prenat Diagn; 2006 Sep; 26(9):819-24. PubMed ID: 16832829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.